It’s finally almost time… This day holds more anticipation than William and Kate’s wedding! (Seriously.) It’s almost Match Day. So what happens if your plans collapse and you don’t Match?
Read More
We’ve previously given you our best tips for passing the NAPLEX on your first try. We even have a post specifically about the California pharmacy law exam. But what we haven’t tackled yet is formulating all our collective knowledge into one post about how to pass any MPJE on the first try. Well, tl;dr friends, today is the day.
Read More
Ever been totally immersed in the methods section of a study paper and wondered, “Why are there so many endpoints? What does it all MEAN?!” Yeah, us too. Which is why we’re going to try to make this essential part of trial endpoint evaluation just a smidge more clear for you.
Read More
With new drugs entering the market all the time and drug prices rapidly increasing, we have to ask the tough question - is the drug worth the cost? Although this question is rarely easy or straightforward to answer, we do have tools available to us to shed some light. Let tl;dr introduce you to the world of pharmacoeconomics!
Read More
Children are just tiny humans, right? Munchkins who function identically to adults, just on a smaller scale? NOT! Today we’re introducing you to a couple reasons why this isn’t true and then reviewing management of several classic pediatric illnesses.
Read More
The p-value and power are the holy grails of statistical significance, right? Let’s make sure you understand them (and how they can be exploited). This article may blow your mind. Journal club just got a whole lot more interesting…
Read More
First there were regular insulins, then intermediate-acting NPH insulins, then long-acting, and most recently ultra long-acting, which is actually still a daily product. So what’s this about a possible once-weekly insulin? Wouldn’t that blow the other so-called long-acting products out of the water? Perhaps it’s time to judge with journal club.
Read More
We spend 4+ years as pharmacists getting our bearings for managing human pharmacotherapy. So what happens when your patient is no longer human? Are there medications on your shelves right now that you might be able to use for your humans’ furry family members?
Read More
UTIs are one of the most common infections you’ll encounter in both the inpatient and the outpatient world. There have been several new drugs approved in the last few years, and there has been a push towards shorter treatment durations. Get yourself caught up to speed with the latest and greatest in UTI treatment.
Read More
Conferences and job interviews have shifted to the virtual realm this year. The skills that gave you success with in-person interviews don’t necessarily apply to the online world. Read this to learn how the game has changed, and what you can do to prepare.
Read More
Odds are that you may not have had a lecture on multiple sclerosis during pharmacy school, but this disease state is more common than previously realized. So you may very well encounter these medications at some point in your career. Plus, it is a HOT area for drug development with FOUR FDA approvals in 2020 alone!
Read More
Febrile Neutropenia is one of the few oncologic emergencies. This post is a crash course in this difficult disease state that will leave you better prepared to treat your patients (even if you’re not an oncology specialist).
Read More